Baylor Scott & White Health
Q&A: Javed Butler, MD, MPH, MBA, discusses the current heart failure medication landscape
Few areas in cardiology are as active as development and implementation of medical therapies for heart failure, and few people are as familiar with that landscape as Javed Butler, MD, MPH, MBA, FACC, FAHA, FESC.
Empagliflozin did not cut risk for death, HF hospitalization after heart attack: EMPACT-MI
ATLANTA — In the EMPACT-MI trial, empagliflozin treatment soon after an acute MI did not significantly lower risk for HF hospitalization or death from any cause compared with placebo among patients with increased risk for HF.
Boy’s mosquito bites develop into ‘impetiginous lesions’ that will not heal
A 5-year-old boy is referred from an Army hospital in Panama in the mid-1980s to Brooke Army Medical Center for evaluation of an unrelated problem when his parent asked about a case of several “impetiginous lesions” that will not heal.
Distal artery access PCI safe vs. proximal access at 1 year; no impact on hand function
Distal radial artery access for PCI showed no significant change in hand function and similar rates of access-site bleeding and radial artery occlusion at 1 year vs. proximal access, a speaker reported.